Press Room

FOR IMMEDIATE RELEASE - February, 2014

Hepatitis B Foundation Welcomes Dr. Robert Gish as Medical Director

Renowned leader in the field of liver disease takes on new role leading advocacy and research

DOYLESTOWN, Pa. (February 10, 2014) – The Hepatitis B Foundation, the only national
nonprofit organization solely dedicated to finding a cure for hepatitis B, is pleased to announce
that Robert G. Gish, M.D., has been named the foundation’s new medical director.

An internationally renowned medical researcher in the field of viral hepatitis, Dr. Gish has made
invaluable contributions to the understanding and treatment of hepatitis B, which is the world’s
leading cause of liver cancer. A longtime supporter of the foundation’s mission and a member of
the Scientific Advisory Board, Dr. Gish’s new role will further strengthen its research and
advocacy efforts worldwide.

“We are delighted to welcome Dr. Gish to our board,” said Dr. W. Thomas London, senior
member emeritus of Fox Chase Cancer Center and vice president of the board of directors of
the Hepatitis B Foundation. “He has long been a leader in the field and has extensive
experience in the conduct of clinical trials of new drugs to combat chronic hepatitis B. His
leadership as medical director will help us advance the treatment and prevent the severe
consequences of this potentially deadly disease.”

After receiving his medical degree in 1980, Dr. Gish quickly developed a keen interest in liver
health, focusing his research on investigation of viral hepatitis B and C. He went on to become
medical director of the liver transplant program at California Pacific Medical Center in 1994,
developing an outreach program that eventually served more than 35,000 patients in northern
California and Nevada and made the medical center a leading liver transplant center.

Over the course of his career, Dr. Gish has published more than 600 original articles, abstracts
and book chapters and more than 120 peer-reviewed publications. Today, he is a clinical
professor of Medicine at the University of Nevada in Las Vegas, where he continues to teach,
and is a senior consultant at St. Joseph’s Medical Center in Phoenix. In 2013, he formed Robert
G. Gish Consultants LLC to support liver health and transplant programs with operations,
outreach, compliance, financial planning and program development in the U.S. and Asia.

“Dr. Gish’s background is a perfect fit for the work we do here at the Foundation and our Baruch
S. Blumberg Institute,” said Dr. Timothy Block, president of the Hepatitis B Foundation and also
a professor of Microbiology at Drexel University. “We are honored that Dr. Gish has agreed to
become our medical director and look forward to many years of collaboration so we can finally
put an end to this serious liver infection.”

About the Hepatitis B Foundation: Headquartered in Doylestown, Pa., the Hepatitis B
Foundation is the only national nonprofit organization solely dedicated to finding a cure for
hepatitis B and improving the quality of life for those affected worldwide through research,
education and patient advocacy. To learn more, go to www.hepb.org, read our blog at wp.hepb.org, follow us on Twitter @HepBFoundation, find us on Facebook at www.facebook.com/hepbfoundation or call 215-489-4900.